TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM |
|
TRIAL 01-16-4 |
Control material NO. | 01-16-4-1 | 01-16-4-2 | 01-16-4-3 | 01-16-4-4 | Non treponemal test | Non Reactive | Non Reactive | NS | Reactive | Treponemal test | Reactive | Reactive | Reactive | Reactive |
|
|
|
TENTATIVE DESIGNATED RESPONSE FOR HEPATTTIS B VIRUS SEROLOGY PROGRAM |
|
TRIAL 02-16-4 |
Control material NO. | 02-16-4-1 | 02-16-4-2 | 02-16-4-3 | 02-16-4-4 | HBsAg | POSITIVE 899.57±108.99 (ECLIA) | POSITIVE 744.45±89316 (ECLIA) | NEGATIVE 0.53±0.13 (ECLIA) | NEGATIVE 0.52± 0.14 (ECLIA) | antiHBs (all methods) (mIU/ml) | NEGATIVE 0.70±1.31 | NEGATIVE 0.70±1.49 | POSITIVE 542.61±153.62 | POSITIVE 322.57±105.91 | antiHBc | POSITIVE | NS | POSITIVE | POSITIVE | HBeAg | NEGATIVE | NEGATIVE | NEGATIVE | NEGATIVE | antiHBe | POSITIVE | POSITIVE | POSITIVE | POSITIVE |
|
|
|
TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM |
|
TRIAL 01-16-3 |
Control material NO. | 01-16-3-1 | 01-16-3-2 | 01-16-3-3 | 01-16-3-4 | Non treponemal test | Reactive | Reactive | Non Reactive | NS | Treponemal test | Reactive | Reactive | Reactive | Reactive |
|
|
|
TENTATIVE DESIGNATED RESPONSE FOR HEPATTTIS B VIRUS SEROLOGY PROGRAM |
|
TRIAL 02-16-3 |
Control material NO. | 02-16-3-1 | 02-16-3-2 | 02-16-3-3 | 02-16-3-4 | HBsAg | NEGATIVE 0.51±0.12 (ECLIA) | NEGATIVE 0.49±0.15 (ECLIA) | POSITIVE 690.69±67.44 (ECLIA) | POSITIVE 1,084.51± 120.03 (ECLIA) | antiHBs (all methods) (mIU/ml) | POSITIVE 424.87±89.98 | POSITIVE 97.57±18.50 | NEGATIVE 0.47±0.86 | NEGATIVE 0.58±0.80 | antiHBc | NS | NS | NS | POSITIVE | HBeAg | NEGATIVE | NEGATIVE | POSITIVE | NEGATIVE | antiHBe | NEGATIVE | POSITIVE | NEGATIVE | POSITIVE |
|
|
|
TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM |
|
TRIAL 01-16-2 |
Control material NO. | 01-16-2-1 | 01-16-2-2 | 01-16-2-3 | 01-16-2-4 | Non treponemal test | Reactive | Reactive | Reactive | NS | Treponemal test | Reactive | Reactive | Reactive | Reactive |
|
|
|
TENTATIVE DESIGNATED RESPONSE FOR HEPATTTIS B VIRUS SEROLOGY PROGRAM |
|
TRIAL 02-16-2 Control material NO. | 02-16-2-1 | 02-16-2-2 | 02-16-2-3 | 02-16-2-4 | HBsAg | NS 28.52±4.50 (ECLIA) | NEGATIVE 0.54±0.14 (ECLIA) | POSITIVE 326.01±48.58 (ECLIA) | NEGATIVE 0.55± 0.15 (ECLIA) | antiHBs (all methods) (mIU/ml) | NEGATIVE 1.25±3.68 | POSITIVE 149.44±34.26 | NEGATIVE 0.76±1.16 | POSITIVE 253.74±93.28 | antiHBc | NS | NS | NS | NS | HBeAg | NEGATIVE | NEGATIVE | NEGATIVE | NEGATIVE | antiHBe | POSITIVE | POSITIVE | POSITIVE | POSITIVE |
|
|
|
TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM |